Penn State scientists have discovered a novel drug target and have rescued functional deficits in human nerve cells derived from patients with Rett Syndrome, a severe form of autism-spectrum disorder. The research, led by Gong Chen, professor of biology and the Verne M. Willaman Chair in Life Sciences at Penn State, could lead to a new treatment for Rett Syndrome and other forms of autism-spectrum disorders. A paper describing the research was published on Jan. 4, 2016, in the online Early Edition of the journal Proceedings of the National Academy of Sciences.
“The most exciting part of this research is that it directly uses human neurons that originated from Rett Syndrome patients as a clinically-relevant disease model to investigate the underlying mechanism,” said Chen. “Therefore, the new drug target discovered in this study might have direct clinical implication in the treatment of Rett Syndrome and potentially for other autism-spectrum disorders as well.”
The researchers differentiated stem cells derived from the skin cells of patients with Rett Syndrome into nerve cells that could be studied in the laboratory. These nerve cells carry a mutation in the gene MECP2, and such gene mutations are believed to be the cause of most cases of Rett Syndrome. The researchers discovered that these nerve cells lacked an important molecule, KCC2, that is critical to normal nerve cell function and brain development.
“KCC2 controls the function of the neurotransmitter GABA at a critical time during early brain development,” Chen said. “Interestingly, when we put KCC2 back into Rett neurons, the GABA function returns to normal. We therefore think that increasing KCC2 function in individuals with Rett Syndrome may lead to a potential new treatment.”
The researchers also showed that treating diseased nerve cells with insulin-like growth factor 1 (IGF1) elevated the level of KCC2 and corrected the function of the GABA neurotransmitter. IGF1 is a molecule that has been shown to alleviate symptoms in a mouse model of Rett Syndrome and is the subject of an ongoing phase-2 clinical trial for the treatment of the disease in humans.
“The finding that IGF1 can rescue the impaired KCC2 level in Rett neurons is important not only because it provides an explanation for the action of IGF1,” said Xin Tang, a graduate student in Chen’s Lab and the first-listed author of the paper, “but also because it opens the possibility of finding more small molecules that can act on KCC2 to treat Rett syndrome and other autism spectrum disorders.”
Read more: Discovery of a new drug target could lead to novel treatment for severe autism
The Latest on: Autism-spectrum disorder
[google_news title=”” keyword=”Autism-spectrum disorder” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Autism-spectrum disorder
- 3 Movies That Totally Misrepresent Psychological Disorderson May 9, 2024 at 7:33 am
Cinema can have a powerful influence on how we perceive the world around us. When it comes to psychology, however, Hollywood often takes creative liberties that lead to misconceptions and stereotypes.
- Study identifies primary cause of sensory hypersensitivity in a mouse model of autism spectrum disorderon May 9, 2024 at 7:23 am
A research team led by Director Kim Eunjoon of the Center for Synaptic Brain Dysfunctions and Director Kim Seong-Gi of the Center for Neuroscience Imaging Research within the Institute for Basic ...
- Autism Spectrum Disorder Warning Signs: What To Look Out Foron May 9, 2024 at 6:25 am
OverviewA neurodevelopment disorder that causes a wide range of impairments in social communication and restricted and repetitive behaviors.SymptomsIf you're experiencing new, severe, or persistent ...
- Australian study finds link between autism, stress disorderon May 8, 2024 at 7:52 pm
CANBERRA - People with autism are more likely to develop post-traumatic stress disorder (PTSD), Australian research has found. In a new study, researchers from the Australian National University (ANU) ...
- Helping your child make friends with a child with autismon May 8, 2024 at 5:17 am
Kids are very likely to make the acquaintance of a child diagnosed with autism spectrum disorder at some point, whether they know it or not. An estimated 95% of children with disabilities enroll in ...
- Abu Dhabi University Boosts Awareness Through Two Educational Events Focused on Autism Spectrum Disorderon May 8, 2024 at 12:31 am
As part of its commitment to the provision of inclusive education, Abu Dhabi University (ADU) hosted two impactful events in collaboration with the Emirates Autism Society (EAS), aimed at raising ...
- Full Spectrum Supporton May 7, 2024 at 11:28 am
(FSS) is a Seminole State College of Florida program developed to facilitate the successful adjustment and progression of college students with autism spectrum disorders (ASD) in all domains of ...
- Council of Autism Service Providers Releases New Practice Guidelines for Treating Autism Spectrum Disorder Using Applied Behavior Analysison May 7, 2024 at 5:00 am
The Council of Autism Service Providers (CASP) has released Version 3.0 of its Applied Behavior Analysis (ABA) Practice Guidelines for the Treatment of Autism Spectrum Disorder. The guidelines help ...
- Norwalk athlete starts basketball organization to spread autism awarenesson May 6, 2024 at 12:44 pm
Carsyn Langhorn, a Connecticut resident who's been interviewed by Knicks legend John Starks, started Carsyn’s Corner to advocate for neurodivergent athletes.
- Can Autism Affect Substance Use or Misuse?on May 6, 2024 at 12:49 am
Studies show that autistic folks may be at higher risk of substance misuse, but that's not the whole story. Let's look deeper.
via Bing News